Literature DB >> 3154831

Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.

H J Yoo, S G Hartling, C Binder.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3154831      PMCID： PMC4534935          DOI： 10.3904/kjim.1987.2.2.196

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN： 1226-3303            Impact factor:   2.884


× No keyword cloud information.
  16 in total

1.  Residual C-peptide production in type I diabetes mellitus. A comparison of different methods of assessment and influence on glucose control.

Authors:  S Sjöberg; R Gunnarsson; J Ostman
Journal:  Acta Med Scand       Date:  1983

2.  Urinary C-peptide: an indicator of beta-cell secretion under different metabolic conditions.

Authors:  P M Blix; C Boddie-Willis; R L Landau; H Rochman; A H Rubenstein
Journal:  J Clin Endocrinol Metab       Date:  1982-03       Impact factor: 5.958

3.  Residual beta-cell function and islet cell antibodies in diabetic children.

Authors:  J R Crossley; A G James; R B Elliot; C C Berryman; B W Edgar
Journal:  Pediatr Res       Date:  1981-01       Impact factor: 3.756

4.  Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).

Authors:  L Gerö; L Korányi; G Tamás
Journal:  Diabete Metab       Date:  1983-09

5.  Urine C-peptide, beta-cell function, and insulin requirement.

Authors:  E B Rappaport; R A Ulstrom; D D Etzwiler; D Fife; B E Hedlund; M W Steffes
Journal:  Am J Dis Child       Date:  1980-12

6.  Urinary C-peptide: a simple measure of integrated insulin production with emphasis on the effects of body size, diet, and corticosteroids.

Authors:  B J Hoogwerf; F C Goetz
Journal:  J Clin Endocrinol Metab       Date:  1983-01       Impact factor: 5.958

7.  Residual B cell function in diabetic children as determined by urinary C-peptide.

Authors:  J Aurbach-Klipper; R Sharph-Dor; L G Heding; M Karp; Z Laron
Journal:  Diabetologia       Date:  1983-02       Impact factor: 10.122

8.  Characterization of seven C-peptide antisera.

Authors:  O K Faber; C Binder; J Markussen; L G Heding; V K Naithani; H Kuzuya; P Blix; D L Horwitz; A H Rubenstein
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

9.  Rapid changes in chromatographically determined haemoglobin A1c induced by short-term changes in glucose concentration.

Authors:  P A Svendsen; J S Christiansen; U Søegaard; B S Welinder; J Nerup
Journal:  Diabetologia       Date:  1980-08       Impact factor: 10.122

10.  Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.

Authors:  G Dahlquist; L Blom; P Bolme; L Hagenfeldt; F Lindgren; B Persson; B Thalme; M Theorell; S Westin
Journal:  Diabetes Care       Date:  1982 Jul-Aug       Impact factor: 19.112
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.